Truist Financial’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $4.19M | Buy |
|
|||||
|
2025
Q2 | $3.83M | Buy |
|
|||||
|
2025
Q1 | $3.37M | Buy |
|
|||||
|
2024
Q4 | $3.06M | Buy |
|
|||||
|
2024
Q3 | $2.29M | Sell |
|
|||||
|
2024
Q2 | $6.5M | Sell |
|
|||||
|
2024
Q1 | $7.35M | Sell |
|
|||||
|
2023
Q4 | $7.04M | Sell |
|
|||||
|
2023
Q3 | $9.85M | Buy |
|
|||||
|
2023
Q2 | $8.88M | Buy |
|
|||||
|
2023
Q1 | $7.66M | Buy |
|
|||||
|
2022
Q4 | $6.66M | Sell |
|
|||||
|
2022
Q3 | $8.27M | Sell |
|
|||||
|
2022
Q2 | $10M | Sell |
|
|||||
|
2022
Q1 | $14.1M | Buy |
|
|||||
|
2021
Q4 | $14.4M | Sell |
|
|||||
|
2021
Q3 | $13.2M | Buy |
|
|||||
|
2021
Q2 | $11.3M | Sell |
|
|||||
|
2021
Q1 | $9.36M | Buy |
|
|||||
|
2020
Q4 | $9.77M | Buy |
|
|||||
|
2020
Q3 | $8.14M | Buy |
|
|||||
|
2020
Q2 | $5.98M | Buy |
|
|||||
|
2020
Q1 | $5.25M | Sell |
|
|||||
|
2019
Q4 | $7.71M | Buy |
|
|||||
|
2019
Q3 | $640K | Sell |
|
|||||
|
2019
Q2 | $625K | Buy |
|
|||||
|
2019
Q1 | $556K | Buy |
|
|||||
|
2018
Q4 | $435K | Sell |
|
|||||
|
2018
Q3 | $520K | Sell |
|
|||||
|
2018
Q2 | $576K | Buy |
|
|||||
|
2018
Q1 | $448K | Sell |
|
|||||
|
2017
Q4 | $514K | Sell |
|
|||||
|
2017
Q3 | $784K | Sell |
|
|||||
|
2017
Q2 | $1.15M | Buy |
|
|||||
|
2017
Q1 | $643K | Buy |
|
|||||
|
2016
Q4 | $602K | Sell |
|
|||||
|
2016
Q3 | $787K | Buy |
|
|||||
|
2016
Q2 | $633K | Buy |
|
|||||
|
2016
Q1 | $502K | Buy |
|
|||||
|
2015
Q4 | $405K | Buy |
|
|||||
|
2013
Q3 | – | Sell |
|
|||||
|
2013
Q2 | $269K | Buy |
|